Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 pseudogene is a non-functional DNA sequence classified as a pseudogene. It closely resembles the active HMGCS1 gene, which encodes an enzyme important for cholesterol biosynthesis, but instead lacks the ability to encode a functional protein. Pseudogenes such as this arise from gene duplication or retrotransposition events and often accumulate mutations that disable protein-coding potential. Most pseudogenes do not have biological functions, though a few can participate in regulation of gene expression via noncoding RNA mechanisms—as described for other pseudogenes, not specifically for this locus. This pseudogene is not considered a therapeutic target, lacks interaction with drugs, and is not used as a biomarker. There are no known safety or therapeutic considerations associated with this locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) pseudogene.